Related Experiment Video

Updated: Jun 11, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

The cardiorenal syndrome in heart failure: an evolving paradigm

Shilpa Kshatriya1, Hani Kozman, Danish Siddiqui

  • 1Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, New York 13210, USA.

The American Journal of the Medical Sciences
|July 9, 2010
PubMed

Insights

Heart failure and kidney dysfunction, known as cardiorenal syndrome, impact many patients. Emerging therapies must address both organs for improved outcomes.

Area of Science:

  • Cardiology and Nephrology
  • Cardiorenal Medicine

Background:

  • Heart failure is a growing cause of illness and death in the US.
  • Renal dysfunction is common in heart failure patients, worsening outcomes.
  • Cardiorenal syndrome involves complex interactions between the heart and kidneys.

Purpose of the Study:

  • To review the pathophysiology and management of cardiorenal syndrome.
  • To highlight the role of neurohumoral mechanisms in cardiorenal interactions.
  • To emphasize the need for integrated treatment strategies.

Main Methods:

  • Literature review of cardiorenal syndrome.
  • Analysis of pathophysiologic mechanisms.
  • Discussion of current and emerging therapeutic approaches.

Main Results:

  • Cardiorenal syndrome is characterized by impaired heart and kidney function.
  • Neurohumoral factors, like natriuretic peptides, play a key role.
  • Sodium retention and volume overload contribute to organ damage.

Conclusions:

  • Cardiorenal syndrome management requires individualized, organ-specific strategies.
  • Emerging therapies should target both cardiac and renal function.
  • A multidisciplinary approach is essential for optimal patient outcomes.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...